期刊
FUTURE MEDICINAL CHEMISTRY
卷 9, 期 17, 页码 2081-2098出版社
FUTURE SCI LTD
DOI: 10.4155/fmc-2017-0089
关键词
cancer; chromatin; epigenetics; histone methylation; post-translational modification; PRMT5; protein methylation
PRMT5 catalyzes the mono-and symmetric dimethylation of the arginine N-guanidine group of a wide variety of target proteins including histones, transcriptional elongation factors, kinases and tumor suppressors by utilizing the essential co-factor S-adenosylmethionine as methyl source. PRMT5 overexpression has been linked to the progression of various diseases, including cancer, and is oftentimes associated with a poor prognosis. Therefore, PRMT5 is promoted as a valuable target for drug discovery approaches and was a subject matter in recent endeavors aiming for the development of specific PRMT5 inhibitors. This review will embrace the significance of PRMT5 as therapeutic target with respect to its molecular inter-dependencies in disease states as well as its implication in drug development approaches.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据